Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA219510
Max Phase: Preclinical
Molecular Formula: C27H27N3O4
Molecular Weight: 457.53
Molecule Type: Small molecule
Associated Items:
ID: ALA219510
Max Phase: Preclinical
Molecular Formula: C27H27N3O4
Molecular Weight: 457.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cn(CCOCCOC(c2ccccc2)(c2ccccc2)c2ccncc2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C27H27N3O4/c1-21-20-30(26(32)29-25(21)31)16-17-33-18-19-34-27(22-8-4-2-5-9-22,23-10-6-3-7-11-23)24-12-14-28-15-13-24/h2-15,20H,16-19H2,1H3,(H,29,31,32)
Standard InChI Key: FALXHDVQJVMXGK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.53 | Molecular Weight (Monoisotopic): 457.2002 | AlogP: 3.27 | #Rotatable Bonds: 10 |
Polar Surface Area: 86.21 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.01 | CX Basic pKa: 4.96 | CX LogP: 3.61 | CX LogD: 3.61 |
Aromatic Rings: 4 | Heavy Atoms: 34 | QED Weighted: 0.37 | Np Likeness Score: -0.78 |
1. Hernandez AI, Familiar O, Negri A, Rodríguez-Barrios F, Gago F, Karlsson A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ.. (2006) N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors., 49 (26): [PMID:17181158] [10.1021/jm0610550] |
Source(1):